Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Trialbee's Jamie Goldfarb Earns Linnea Olson Award for Lifelong Advocacy Connecting Patients With Clinical Research


News provided by

Trialbee

Nov 08, 2023, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Jamie Goldfarb | 2023 Linnea Olson Award | Trialbee
Jamie Goldfarb | 2023 Linnea Olson Award | Trialbee

Goldfarb's cancer battle and life-changing clinical trial experience inspire her passionate and consistent outreach to engage patient communities

CHAPEL HILL, N.C. and MALMO, Sweden, Nov. 8, 2023 /PRNewswire-PRWeb/ -- Trialbee, the global team revolutionizing the patient recruitment ecosystem with technology, people, and passion, today announced Jamie Goldfarb, its Director of Patient Recruitment Strategy, was named the recipient of the 2023 Linnea Olson Award for lifelong achievements in patient advocacy.

Established in 2022 by Medidata, a Dassault SystHmes (Euronext Paris: FR0014003TT8, DSY.PA) company and leading provider of clinical trial solutions to the life sciences industry, the award recognizes an individual who is dedicated to improving the patient experience in clinical research. It honors the life and legacy of Linnea Olson, a founding member of Medidata's Patient Insights Board who lived with metastatic lung cancer for more than 16 years and participated in six first-in-human clinical trials. Medidata created the award in her name posthumously last year.

"It's not just about how she has carried herself in the face of tremendous adversity. It's about how she has channeled her struggles into empowering and uplifting others facing similar battles." - Matt Walz, Trialbee CEO

Post this

Goldfarb was diagnosed with melanoma for a third time in January 2011 — 11 weeks after giving birth to her son, Kai. The cancer had reached stage 4 by metastasizing to her liver and pancreas, and Goldfarb enrolled in a clinical trial for tumor-infiltrating lymphocyte (TIL) therapy as part of her treatment.

Because of the clinical trial, she reached no evidence of disease two years post treatment (during which time the 40-plus tumors all over her body shrank until they disappeared) and has remained disease free for the past 11 years.

Throughout her experience, Goldfarb realized not all patients are aware of clinical research opportunities that may be available to them, especially in oncology. As a result, she embraced the opportunity to be a vocal patient advocate even outside of her professional responsibilities in clinical trial patient recruitment by speaking at industry and patient conferences, writing articles and white papers, speaking with the media about the importance of clinical trials, and working one-on-one with people with cancer to help them navigate their treatment options.

"This is a humbling recognition for something I'm very passionate about," Goldfarb said. "I don't share my story because I want to be in the spotlight. I do it because a clinical trial saved my life, yet less than 5% of patients with cancer ever participate in clinical research. I want everyone to understand the power and potential of clinical trials as a treatment option — and more importantly, I want to provide hope and clarity to anyone who feels like they're up against the odds during a discouraging and confusing time."

Goldfarb gave the keynote address at the Melanoma Research Alliance's (MRA) annual scientific retreat in Washington, D.C., in March and has spoken about how medical professionals must improve awareness of clinical trials among patients at various industry events.

Goldfarb has been a research advocate for the National Cancer Institute (NCI), which uses her perspective to ensure the patient's experience is considered throughout the research process. She is one of the patient moderators of the MRA's patient forum, and created patient-centric online clinical trial resources for the organization as well as several top-20 global pharmaceutical companies. She is also heavily involved with the Melanoma International Foundation (MIF), the Melanoma Research Foundation (MRF), the Alliance for Regenerative Medicine (ARM), the Association of Clinical Research Professionals (ACRP), and Imerman Angels. She and her husband, Jeff, have met with members of Congress to push for increased funding for the NCI and National Institutes of Health (NIH).

As valuable as her public advocacy work is, Goldfarb believes one-on-one outreach with patients makes the greatest difference. She helps them navigate their treatment options, including how medical research works, what a clinical trial is, and whether it's right for them. She then connects them with others battling cancer so they can build a stronger support system.

"In a sea of worthy and passionate candidates, there's no one more deserving than Jamie," said Matt Walz, CEO of Trialbee. "It's not just about how she has carried herself in the face of tremendous adversity. It's about how she has channeled her struggles into empowering and uplifting others facing similar battles. Jamie embodies hope and resiliency in the most inspiring way. She's been an incredible asset to the Trialbee family, and we are lucky to have her."

Goldfarb accepted the Linnea Olson Award at the Medidata NEXT New York conference at the Sheraton New York Times Square Hotel on November 7.

"I just want patients to always remember they are not alone," Goldfarb said. "Talk to friends. Family. Healthcare providers. Don't stop talking until you understand all your options."

About Trialbee

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company's vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment – providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on patient advocacy, community engagement, and diversity. To take control of patient recruitment for your next study, visit http://www.trialbee.com/.

Media Contact

Kristopher Sarajian, Trialbee, 1 6102282096, [email protected], www.trialbee.com

SOURCE Trialbee

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.